ETF Capital Rankings | Guotai Innovative Drug ETF (517110): Net inflow of 11.0385 million yuan, ranking first among comparable funds - April 21, 2026
On April 21, 2026, Guotai Innovative Drug ETF (517110.SH) closed down 1.21%, with a turnover of 5.9541 million yuan. Net inflow reached 11.0385 million yuan (net subscription shares * unit net value), ranking first among comparable funds.
Over a longer period, this fund has seen continuous net inflows for four days, accumulating a total of 21.5457 million yuan, ranking among the top two comparable funds.
Capital inflows have also contributed to an increase in shares. The latest share volume of this fund increased by 15 million shares from the previous day, surpassing 700 million shares, ranking first among comparable funds. Meanwhile, the latest scale of this fund exceeded 520 million yuan, ranking first among comparable funds.
Guotai Innovative Drug ETF (517110.SH), off-exchange linkage (A: 014117; C: 014118).
Disclaimer: The above content and data are unrelated to the position of Youlian Cloud and do not constitute investment advice. Any actions taken based on this information are at the investor’s own risk.
Risk Disclaimer: The above content only represents the author's view. It does not represent any position or investment advice of Futu. Futu makes no representation or warranty.Read more
Comments
to post a comment